Pivotal Roles of GM-CSF in Autoimmunity and Inflammation

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2015 Apr 4

PMID 25838639

Citations 112

Authors

Aoi Shiomi

Takashi Usui

Affiliations

Soon will be listed here.

Abstract

Granulocyte macrophage-colony stimulating factor (GM-CSF) is a hematopoietic growth factor, which stimulates the proliferation of granulocytes and macrophages from bone marrow precursor cells. In autoimmune and inflammatory diseases, Th17 cells have been considered as strong inducers of tissue inflammation. However, recent evidence indicates that GM-CSF has prominent proinflammatory functions and that this growth factor (not IL-17) is critical for the pathogenicity of CD4(+) T cells. Therefore, the mechanism of GM-CSF-producing CD4(+) T cell differentiation and the role of GM-CSF in the development of autoimmune and inflammatory diseases are gaining increasing attention. This review summarizes the latest knowledge of GM-CSF and its relationship with autoimmune and inflammatory diseases. The potential therapies targeting GM-CSF as well as their possible side effects have also been addressed in this review.

Citing Articles

Paracrine Activation of STAT3 Drives GM-CSF Expression in Breast Carcinoma Cells, Generating a Symbiotic Signaling Network with Breast Carcinoma-Associated Fibroblasts.

Osuala K, Chalasani A, Aggarwal N, Ji K, Moin K Cancers (Basel). 2024; 16(16).

PMID: 39199680 PMC: 11353178. DOI: 10.3390/cancers16162910.

Immunotherapeutic implications on targeting the cytokines produced in rhinovirus-induced immunoreactions.

Sang L, Gong X, Huang Y, Zhang L, Sun J Front Allergy. 2024; 5:1427762.

PMID: 38859875 PMC: 11163110. DOI: 10.3389/falgy.2024.1427762.

GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease.

Li H, Cao X, Gu X, Dong M, Huang L, Mao C Neurosci Bull. 2023; 40(4):451-465.

PMID: 38113014 PMC: 11003948. DOI: 10.1007/s12264-023-01158-y.

The Cytokine Profile in Different Stages of Schistosomiasis Japonica.

Wang X, Tang Q, Bergquist R, Zhou X, Qin Z Pathogens. 2023; 12(10).

PMID: 37887717 PMC: 10610117. DOI: 10.3390/pathogens12101201.

Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis.

Zareinejad M, Mehdipour F, Roshan-Zamir M, Faghih Z, Ghaderi A Cancers (Basel). 2023; 15(19).

PMID: 37835465 PMC: 10571747. DOI: 10.3390/cancers15194771.

References

Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S . IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol. 2006; 177(1):566-73. DOI: 10.4049/jimmunol.177.1.566. View

Noster R, Riedel R, Mashreghi M, Radbruch H, Harms L, Haftmann C . IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci Transl Med. 2014; 6(241):241ra80. DOI: 10.1126/scitranslmed.3008706. View

Colotta F, Bussolino F, Polentarutti N, Guglielmetti A, Sironi M, Bocchietto E . Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells. Exp Cell Res. 1993; 206(2):311-7. DOI: 10.1006/excr.1993.1151. View

Sonderegger I, Iezzi G, Maier R, Schmitz N, Kurrer M, Kopf M . GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J Exp Med. 2008; 205(10):2281-94. PMC: 2556786. DOI: 10.1084/jem.20071119. View

Cousins D, Lee T, Staynov D . Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol. 2002; 169(5):2498-506. DOI: 10.4049/jimmunol.169.5.2498. View

Xu Y, Hunt N, Bao S . The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Cell Res. 2008; 18(12):1220-9. DOI: 10.1038/cr.2008.310. View

Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B . Phenotypic and functional features of human Th17 cells. J Exp Med. 2007; 204(8):1849-61. PMC: 2118657. DOI: 10.1084/jem.20070663. View

Hamilton J . GM-CSF in inflammation and autoimmunity. Trends Immunol. 2002; 23(8):403-8. DOI: 10.1016/s1471-4906(02)02260-3. View

Kleinewietfeld M, Hafler D . The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol. 2013; 25(4):305-12. PMC: 3905679. DOI: 10.1016/j.smim.2013.10.009. View

10.

Lukens J, Barr M, Chaplin D, Chi H, Kanneganti T . Inflammasome-derived IL-1β regulates the production of GM-CSF by CD4(+) T cells and γδ T cells. J Immunol. 2012; 188(7):3107-15. PMC: 3758236. DOI: 10.4049/jimmunol.1103308. View

11.

Burmester G, Feist E, Sleeman M, Wang B, White B, Magrini F . Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study. Ann Rheum Dis. 2011; 70(9):1542-9. PMC: 3147227. DOI: 10.1136/ard.2010.146225. View

12.

Garcia J, James H, Zinkgraf S, Perlman M, Keogh B . Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury. Am Rev Respir Dis. 1987; 136(4):811-7. DOI: 10.1164/ajrccm/136.4.811. View

13.

Acosta-Rodriguez E, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A . Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007; 8(6):639-46. DOI: 10.1038/ni1467. View

14.

Sakagami T, Uchida K, Suzuki T, Carey B, Wood R, Wert S . Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med. 2010; 361(27):2679-81. PMC: 4174270. DOI: 10.1056/NEJMc0904077. View

15.

Tazawa R, Trapnell B, Inoue Y, Arai T, Takada T, Nasuhara Y . Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2010; 181(12):1345-54. PMC: 2894410. DOI: 10.1164/rccm.200906-0978OC. View

16.

Pignatti P, Brunetti G, Moretto D, Yacoub M, Fiori M, Balbi B . Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am J Respir Crit Care Med. 2005; 173(3):310-7. DOI: 10.1164/rccm.200502-244OC. View

17.

Cook A, Braine E, Campbell I, Rich M, Hamilton J . Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 2001; 3(5):293-8. PMC: 64841. DOI: 10.1186/ar318. View

18.

Kavuru M, Malur A, Marshall I, Barna B, Meziane M, Huizar I . An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011; 38(6):1361-7. PMC: 3874725. DOI: 10.1183/09031936.00197710. View

19.

Gross T, Hunninghake G . Idiopathic pulmonary fibrosis. N Engl J Med. 2001; 345(7):517-25. DOI: 10.1056/NEJMra003200. View

20.

Bruhl H, Cihak J, Niedermeier M, Denzel A, Rodriguez Gomez M, Talke Y . Important role of interleukin-3 in the early phase of collagen-induced arthritis. Arthritis Rheum. 2009; 60(5):1352-61. DOI: 10.1002/art.24441. View